Clinical Trial Update: A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease [NA]

View source ↗

Summary

A clinical trial update indicates the treatment IND study of Zidovudine (AZT) for pediatric HIV infection has completed under the NIAID sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Retrovir (zidovudine) (zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED